ReviewNature materials2026
Minimally invasive bioelectronic implants.
Review in Nature materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Bioelectronic implants enable therapeutic and diagnostic intervention of physiological systems by interfacing electronic devices with living tissues. However, conventional implant strategies often require highly invasive surgical procedures, such as thoracotomies and craniotomies, motivating the development of minimally invasive bioelectronic systems that can be precisely deployed and operated while reducing tissue trauma, recovery time and long-term complications. This Review highlights recent advancements in minimally invasive bioelectronic systems within specified anatomical sites. Originating from techniques used in stent and catheter development, current bioelectronic platforms are now designed with a dual focus on optimizing macroscale ergonomics and achieving seamless integration with the dynamic internal biological environment. Recent innovations include miniaturized neural probes, optoelectronic cardiac pacemakers and bioadhesive cardiac pacing leads. These devices use advanced materials, including shape-memory alloys, programmable polymers and dynamic actuators, to combine structural versatility with multifunctional performance. Looking ahead, emerging designs are expected to leverage retrievable implants, expandable occluders and responsive structures that enable facile deployment and superior adaptation to tissue motion, thereby reducing mechanical mismatch and enhancing long-term biocompatibility. By advancing minimally invasive delivery and patient-specific design, bioelectronics is positioned to enable more effective and personalized clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.